Generic Name<\/p>\n
Doxorubicin hydrochloride liposome<\/p>\n
Indications<\/p>\n
Indicated for treating ovarian cancer that has progressed or recurred after platinum-based treatment, AIDS-related Kaposi’s sarcoma when other systemic therapies have failed, and multiple myeloma in patients who haven’t received bortezomib and have had at least one prior therapy.<\/p>\n
Strength<\/p>\n
2 mg\/ml<\/p>\n
Pack Size<\/p>\n
1\u2019s<\/p>\n
Dosage Form<\/p>\n
Injection<\/p>\n
Categories<\/p>\n
Pharmaceutical<\/p>\n
Therapeutic Class<\/p>\n
Anti-cancer<\/p>\n","protected":false},"featured_media":967,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[19],"product_tag":[],"class_list":["post-924","product","type-product","status-publish","has-post-thumbnail","product_cat-uncategorized","first","instock","shipping-taxable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/macter.com\/index.php\/wp-json\/wp\/v2\/product\/924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/macter.com\/index.php\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/macter.com\/index.php\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/macter.com\/index.php\/wp-json\/wp\/v2\/comments?post=924"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/macter.com\/index.php\/wp-json\/wp\/v2\/media\/967"}],"wp:attachment":[{"href":"https:\/\/macter.com\/index.php\/wp-json\/wp\/v2\/media?parent=924"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/macter.com\/index.php\/wp-json\/wp\/v2\/product_brand?post=924"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/macter.com\/index.php\/wp-json\/wp\/v2\/product_cat?post=924"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/macter.com\/index.php\/wp-json\/wp\/v2\/product_tag?post=924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}